Custom service
Glycopeptides Synthesis Service
Synthesize glycopeptides with defined glycan structures and linkage sites
Glycopeptides Synthesis Service supports programmes that synthesize glycopeptides with defined glycan structures and linkage sites. In a typical engagement we plan the pre-glycosylated building-block incorporation route first, confirm compatibility with enzymatic transglycosylation on peptidyl scaffolds, and release glycopeptide with glycan identity and site-occupancy data on a 5–9 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep pre-glycosylated building-block incorporation as the primary option and hold enzymatic transglycosylation on peptidyl scaffolds in reserve, so that scale-up never depends on an unproven step.
Mucin-type O-glycopeptides for tumour-immunology work
N-glycosylated model peptides for lectin studies
Milligram-to-gram GMP glycopeptide supply
Modifications requiring radiological or BSL-3 containment
Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.
Service Highlights
- Pre-glycosylated building-block incorporation as the default route, with enzymatic transglycosylation on peptidyl scaffolds held as a proven fallback
- Labile-glycan protecting strategy worked into the design where the application requires it
- Modification sites are mapped on the sequence and confirmed by MS/MS before release
- Analytical confirmation of every intermediate before the final release
- Modified and unmodified species are separated and quantified, not just reported
- Glycopeptide with glycan identity and site-occupancy data delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence & modification map
We annotate every modification site, protection strategy and analytical target before synthesis starts.
Solid-phase assembly
The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.
Modification chemistry
Post-synthesis steps — pre-glycosylated building-block incorporation, enzymatic transglycosylation on peptidyl scaffolds — are run under conditions validated on a test cleavage.
Cleavage & purification
Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.
Analytical release
Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.
Documentation
Glycopeptide with glycan identity and site-occupancy data is released with the batch record and analytical package after QC sign-off.
Specifications & timeline
- Turnaround
- 5–9 weeks
- Typical scale
- 0.5 mg – 1 g modified peptide
- Chemistry options
- pre-glycosylated building-block incorporation; enzymatic transglycosylation on peptidyl scaffolds; labile-glycan protecting strategy
- Deliverable
- Glycopeptide with glycan identity and site-occupancy data
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
- Shipping
- Ambient or blue ice as stability data dictate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.